Tag: Ovarian Cancer
May 30, 2019
OncBioMune Announces Initial In Vitro Proof-of-Concept Data for PGT in a Multi-Drug Resistant Ovarian Cancer Model
OncBioMune Pharmaceuticals (OTCQB:OBMP) has announced results of its in vitro data for PGT in a multi-drug resistant ovarian cancer model....
September 28, 2018
Big News Roundup: Relay Medical To Commence Trading in United States as RYMDF; BriaCell Announces Positive Phase IIa Proof of Concept Data in Advanced Breast Cancer; Initiates Combination Study; Kalytera Announces Progress with Cannabinoid-Based Compound for Treatment of Acute and Chronic Pain
In case you missed it, here is this week's big news roundup in the Life Science sector. May 9, 2018
OncoMed Announces First Quarter 2018 Financial Results and Operational Highlights
OncoMed Pharmaceuticals (NASDAQ:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, today announced first quarter 2018...
April 30, 2018
8 Glioblastoma Treatment Stocks
With an average survival rate of 16 months, glioblastoma is the most common and deadly type of brain cancer, accounting... April 30, 2018
Cytori Provides Update on US Manufacturing and EU Approval Plans for ATI-0918, Liposomal Doxorubicin
Cytori Therapeutics (Nasdaq:CYTX) provided an update on its plans for US manufacturing and EU approval for its ATI-0918 liposomal doxorubicin product....
April 29, 2018
5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent
Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 24, 2018